1 asset in Acute Myeloid Leukemia, Biallelic CEBPA Gene Mutation

Therapeutic assets addressing Acute Myeloid Leukemia, Biallelic CEBPA Gene Mutation, rated under Floatz methodology v0.2 and sorted by current rating.